- 专利标题: Sustained-release formulations of topiramate
-
申请号: US14630099申请日: 2015-02-24
-
公开(公告)号: US09555004B2公开(公告)日: 2017-01-31
- 发明人: Likan Liang , Hua Wang , Padmanabh P. Bhatt , Michael L. Vieira
- 申请人: Supernus Pharmaceuticals, Inc.
- 申请人地址: US MD Rockville
- 专利权人: Supernus Pharmaceuticals, Inc.
- 当前专利权人: Supernus Pharmaceuticals, Inc.
- 当前专利权人地址: US MD Rockville
- 代理机构: Foley & Lardner LLP
- 代理商 Sunit Talapatra
- 主分类号: A61K9/16
- IPC分类号: A61K9/16 ; A61K9/50 ; A61K9/24 ; A61K31/357 ; A61K47/48 ; B82Y5/00 ; A61K31/7048
摘要:
Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
公开/授权文献
- US20160022596A1 SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE 公开/授权日:2016-01-28
信息查询